REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Strides Pharma Global Pte. Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Strides Pharma Global Pte. Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Primary Business Activity: manufacture of pharmaceutical products and preparations for human use (e.g. tableted products) (mfg devt mrktg trdg in pharmaceutical pdts & ancillary activities); Secondary Business Activity: other holding companies (acquiring and holding entities engaged in the pharmaceutical business)

Headquarters
3 Tuas South Avenue 4, Singapore
Singapore; Singapore; Postal Code: 637610

Contact Details: Purchase the Strides Pharma Global Pte. Limited report to view the information.

Basic Information
Total Employees:
Purchase the Strides Pharma Global Pte. Limited report to view the information.
Outstanding Shares:
Purchase the Strides Pharma Global Pte. Limited report to view the information.
Registered Capital:
Purchase the Strides Pharma Global Pte. Limited report to view the information.
Financial Auditors:
Purchase the Strides Pharma Global Pte. Limited report to view the information.
Incorporation Date:
August 21, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Strides Pharma Global Pte. Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
37.76%▲
Total operating revenue
37.76%▲
Net Profit (Loss) for the Period
29.71%▲
Total assets
-19.5%▼
Total equity
-24.57%▼
Net Profit Margin
22.11%▲
Return on Equity (ROE)
2.43%▲

Similar companies

Pfizer Asia Manufacturing Pte. Ltd.
 
Organon Asia Pacific Services Pte. Ltd.
Viatris Asia Pacific Pte. Ltd.
 
Edwards Lifesciences (Singapore) Pte. Ltd.
Amgen Singapore Manufacturing Pte. Ltd.
 
Cardinal Health Singapore 225 Pte. Ltd.
Abbvie Operations Singapore Pte. Ltd.
 
West Pharmaceutical Services Singapore Pte. Ltd.
Haw Par Corporation Limited
 
Beecham Pharmaceuticals (Pte) Ltd.
Mp Biomedicals Asia Pacific Pte. Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo